North America Wound Care Market

The North America wound care market is expected to grow from US$ 7,920.27 million in 2022 to US$ 11,178.22 million by 2028. It is estimated to register a CAGR of 5.9% from 2022 to 2028.

Rising Prevalence of Chronic Diseases and Related Wounds Fuels North America Wound Care Market Growth

Chronic diseases such as diabetes, cancer, and other autoimmune disorders directly impact the body's natural healing ability. Diabetes and immunodeficiency conditions are among the most detrimental conditions that can slow down the speed of the wound repair process. Diabetes is the most identified chronic disease. The disease adversely impacts the immune system, which can complicate wound healing. As per NCBI, as of July 2021, nearly 500 million people are estimated to be suffering from diabetes mellitus (DM), with a predicted startling increase in the coming years. In the US alone, over US$300 billion are spent annually on medical costs and as the result of lost workdays due to DM. Moreover, as per a study titled Diabetic Wound-Healing Science by National Center for Biotechnology Information (NCBI), between 1 in 3 overall population and 1 in every 5 DM patients will develop a chronic nonhealing wound, such as a diabetic foot ulcer (DFU), in their lifetime. The hyperglycemic environment promotes the formation of biofilms and makes diabetic wounds difficult to treat. The prolonged healing process due to chronic diseases leads to a long-term need for wound dressings, resulting in high demand for them. Moreover, the increased prevalence of cancer has fueled the number of interventions performed. As a result, wound dressings are often used to prevent postoperative wound infections. Most surgical wounds after cancer surgery are large and deep, resulting in exudate that requires frequent management. Advanced wound dressings such as hydrogels, alginates, and foams help in wound management and infection prevention. As a result, the rise in the prevalence of chronic diseases is propelling the demand for wound care products, fueling the North America wound care market.

North America Wound Care Market Overview

The North America wound care market is segmented into the US, Canada, and Mexico. The US dominated the market in 2022. Chronic ulcers and diabetes have been the leading factors causing chronic wounds in the country. According to a study published by the National Library of Medicine in the US, primary diagnosis of chronic ulcers is conservatively estimated to cost US$28 billion yearly, and secondary diagnosis is expected to cost up to US$ 31.7 billion annually. According to the American Diabetes Association (ADA), over 9–12 million Americans suffer from chronic ulcers. The mortality rate for leg ulcers after the first amputation has dramatically doubled from 20% to 50% in the first three years to 70% after five years. According to Mary Ann Liebert, Inc., publishers in the US, 3% of the population older than 65 years has open wounds. The US government estimates that the elderly population will be over 77 million by 2060, suggesting that chronic wounds will continue to be an increasingly persistent problem in this population. Thus, the rising aging population propels the demand for wound care treatments, favoring the US wound care market growth.

North America Wound Care Market Revenue and Forecast to 2028 (US$ Million)

North America Wound Care Strategic Insights

Strategic insights for the North America Wound Care provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

North America Wound Care Report Scope

North America Wound Care Regional Insights

The geographic scope of the North America Wound Care refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

North America Wound Care Market Segmentation  

The North America wound care market is segmented on the basis of product, wound type, end user, and country.

Based on product, the North America wound care market is segmented into advanced wound dressing, surgical wound care, traditional wound care, and wound therapy devices. The advanced wound dressing segment held the largest market share in 2022.

Based on wound type, the North America wound care market is bifurcated into chronic wounds and acute wounds. The chronic wounds segment held a larger market share in 2022.  

Based on end user, the North America wound care market is segmented into hospitals, specialty clinics, home healthcare, and others. The hospitals segment held the largest market share in 2022.

Based on country, the North America wound care market is segmented into the US, Canada, and Mexico. The US dominated the North America wound care market in 2022.   

3M Co, Baxter International Inc, Coloplast AS, ConvaTec Group Plc, Ethicon USA LLC, Integra LifeSciences Holdings Corp, Medtronic Plc, MiMedx, PAUL HARTMANN AG, and Smith & Nephew Plc are among the leading companies operating in the North America wound care market.